5,779 Shares in Revvity, Inc. (NYSE:RVTY) Acquired by Oak Thistle LLC

Oak Thistle LLC purchased a new position in Revvity, Inc. (NYSE:RVTY) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 5,779 shares of the company’s stock, valued at approximately $607,000.

Several other hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. bought a new stake in Revvity during the 3rd quarter valued at $1,579,487,000. Capital Research Global Investors bought a new stake in shares of Revvity in the 4th quarter worth $838,080,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Revvity in the 4th quarter worth $188,368,000. Norges Bank bought a new stake in shares of Revvity in the 4th quarter worth $129,483,000. Finally, Northern Trust Corp bought a new stake in shares of Revvity in the 4th quarter worth $127,401,000. Institutional investors own 86.65% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Robert W. Baird lifted their target price on Revvity from $126.00 to $127.00 and gave the stock an “outperform” rating in a report on Tuesday, April 30th. Jefferies Financial Group assumed coverage on Revvity in a report on Monday, June 3rd. They issued a “hold” rating and a $115.00 target price on the stock. Barclays decreased their target price on Revvity from $116.00 to $115.00 and set an “equal weight” rating on the stock in a report on Friday. Finally, TD Cowen lifted their target price on Revvity from $123.00 to $130.00 and gave the stock a “buy” rating in a report on Tuesday, April 30th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $118.69.

Insider Activity at Revvity

In related news, insider Joel S. Goldberg sold 4,000 shares of the stock in a transaction that occurred on Friday, June 7th. The stock was sold at an average price of $110.46, for a total transaction of $441,840.00. Following the sale, the insider now directly owns 36,900 shares in the company, valued at approximately $4,075,974. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 0.60% of the stock is currently owned by insiders.

Revvity Stock Performance

Shares of NYSE RVTY traded down $1.86 during trading hours on Monday, hitting $103.00. 1,070,691 shares of the company’s stock were exchanged, compared to its average volume of 871,675. Revvity, Inc. has a 1-year low of $79.50 and a 1-year high of $131.96. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.92. The stock has a market capitalization of $12.71 billion, a price-to-earnings ratio of 85.12, a PEG ratio of 2.73 and a beta of 1.05. The company’s 50-day moving average price is $107.20 and its 200-day moving average price is $106.37.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Monday, April 29th. The company reported $0.98 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.04. The firm had revenue of $649.90 million for the quarter, compared to analyst estimates of $646.83 million. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The business’s revenue for the quarter was down 3.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.01 EPS. On average, sell-side analysts expect that Revvity, Inc. will post 4.65 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Investors of record on Friday, July 19th will be given a dividend of $0.07 per share. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date is Friday, July 19th. Revvity’s dividend payout ratio (DPR) is currently 23.14%.

Revvity Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.